Steroids are essential molecules for life in all complex organisms such as animals and plants. Researchers from the VIB-UGent Center for Plant Systems Biology, the University of Technology Sydney Climate Change Cluster and the University of Queensland have now discovered a new central enzyme in the steroid biosynthesis pathway in some modern organisms. This might not only lead to an evolutionary "re-think" but also opens new ways to control toxic algae in aquaculture. Their findings have been published in Nature Microbiology.
The increasing availability of genome editing tools such as CRISPR/Cas9 is giving scientists unprecedented access to many of the inner metabolic processes that have evolved over billions of years to shape the tree of life. A new study exploring steroid biosynthesis pathways in a group of microalgae called diatoms, urges a rethink on key evolutionary aspects of eukaryotic life, the scientists say.
Knowing the underlying natural metabolism of diatoms is necessary to design synthetic biology and metabolic engineering strategies for the growing biotechnology sector. In addition, the findings, published in Nature Microbiology, have potential practical applications for the aquaculture industry providing insight into ways to inhibit toxic algal infections.
The study is an international collaboration co-led by the University of Technology Sydney Climate Change Cluster (UTSC3) and VIB-Ghent University scientists together with the University of Queensland.
Dr Michele Fabris, co-author and CSIRO Synthetic Biology Future Science Platform Fellow at UTSC3 says that the team's interest was sparked by earlier research suggesting a novel, alternative enzyme for steroid biosynthesis might be "hiding" in some microalgae species.
"Sterols are essential components of all eukaryotic cells. Without sterols plants, animals, and fungi couldn't live. We all rely on the same ancient metabolic machinery in our cells that emerged more than two billion years ago. Or so we thought," he says.
Prof Alain Goossens, a leading specialist in plant metabolism at VIB-UGent Center for Plant Systems Biology says that according to the biochemistry textbooks the enzyme responsible for the first and most important step in sterol biosynthesis, squalene epoxidase, SQE, was believed to have been carried on by all modern organisms from their common ancestor.
Lead author, VIB-UGent researcher Dr Jacob Pollier says that to the contrary they found "many organisms use an alternative, completely different enzyme, an alternative SQE (AltSQE)".
"Nature has come up with a different way of carrying out a function that is key to life. We don't know why yet, but it has profound implications on our understanding of the evolution of life as we know it," he says.
A rethink on accepted view about steroid biosynthesis may also open potential routes to control harmful toxic algae and parasitic infections that impact the aquaculture industry, causing seafood poisoning in humans and economic damage, respectively. Although not the focus of this study, the discovery of this novel enzyme could find applications in this space.
"Because the sterol pathway is a necessary function for these organisms, the enzyme carrying out the key step may offer a novel, potential 'kill' switch, if properly targeted," Dr Fabris says.
The researchers also found one more surprise. The same AltSQE gene was discovered in a class of marine viruses associated with infections and large-scale die offs in algal blooms, which could seed cloud formation.
"Algae blooms are thought to influence cloud formation and thus, ultimately, the Earth's climate system. These marine viruses are known to hijack algal steroid metabolism, so AltSQE could play an important role in marine cloud formation and climate regulation" Dr Pollier says
###
Publication
A widespread alternative squalene epoxidase participates in eukaryote steroid biosynthesis, Pollier et al., Nature Microbiology 2018
Questions from patients
A breakthrough in research is not the same as a breakthrough in medicine. The realizations of VIB researchers can form the basis of new therapies, but the development path still takes years. This can raise a lot of questions. That is why we ask you to please refer questions in your report or article to the email address that VIB makes available for this purpose: patienteninfo@vib.be. Everyone can submit questions concerning this and other medically-oriented research directly to VIB via this address.
Journal
Nature Microbiology